GCC pharma summit highlights improvements in production and regulatory environment

GCC pharma summit highlights improvements in production and regulatory environment

The importance of data and quality management in expediting drug registration and ensuring a safer community was also emphasized by the speakers, especially in the context of the COVID-19 crisis, which called for faster responses in terms of drug trials, approvals and import.



The UAE experience in leveraging its competitive logistics network and ongoing transition into a digital economy to ensure adequate supplies of health essentials across the region was also shared by experts during the two-day summit, held 22-23 July 2020.



His Excellency Dr Amin Hussain Al Amiri, Undersecretary of Public Health Policy & Licensing Sector in the UAE Ministry of Health and Prevention, said in his keynote address: "The well-monitored and well-controlled pharmaceutical production, strong regulatory system and superior logistics in the UAE have supported patients, economies and societies globally, especially during the ongoing efforts to contain the COVID-19 threat. As of July 19, the MOHAP has approved the export of 450 shipments of varied healthcare and hygiene essentials, including COVID-19 diagnostic kits, ventilators, PPE kits, IV solutions, sanitizers and related raw materials worth over AED 243 million to mainly GCC States, Europe, Australia and the US, in addition to countries in the Middle East, as requested by global